Roche Releases Community Statement on RG7916 and Olesoxime Programs
Roche has provided the following community statement on RG7916 and Olesoxime investigational programs. Dear SMA Community, We are very pleased to share an update of the Roche SMA program We have two investigational molecules in development for people with SMA, olesoxime and RG7916. Both molecules are given by mouth (or g-tube) and work in different […]
Roche Releases Community Statement on RG7916 and Olesoxime Programs Read More »








